Regulatory Genome Development, a commercial spinout from the University of Cambridge, has raised £4.6 million seed funding.

RegGenome’s vision is to transform the way the world consumes regulatory information. The company provides structured machine-readable regulatory content that is dynamic, granular and interoperable, all powered by AI-based textual information extraction techniques. 

This enables regulatory authorities to increase accessibility and dissemination of regulatory information and empowers organisations to deepen their regulatory intelligence and digitise their compliance and risk management processes. 

The funding was led by Evolution Equity Partners, with participation from AlbionVC, Cambridge Enterprise and Mastercard. Richard Seewald, managing partner of Evolution Equity Partners, will join RegGenome’s board of directors.

“Deepening regulatory intelligence and digitising compliance and risk management functions utilising machine learning and interoperability with cybersecurity, FinTech and ESG presents tremendous opportunity for the company,” said Richard Seewald, founder and managing partner at Evolution Equity Partners.

Dr Marcio Siqueira, head of physical sciences, Cambridge Enterprise, added: “RegGenome is a superb example of how the University of Cambridge’s transformational intellectual property can be applied for global impact. 

“RegGenome is primed to deliver a quantum leap in how regulatory content is shared and harnessed. We are looking forward to seeing RegGenome’s vision come to life.”